Home › Cardiotoxicity › Massachusetts
Cardiotoxicity clinical trials in Massachusetts
3 studies for Cardiotoxicity are looking for participants at sites in Massachusetts.
The CARDIOPROTECT Trial
- Beth Israel Deaconess Medical Center, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT07654426The STOP-MED CTRCD Trial
- Brigham and Women's Hospital, Boston
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT06183437S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Lahey Hospital and Medical Center, Burlington
- Winchester Hospital, Winchester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.